We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
-5%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.45B
AUM Growth
+$12.9M
(+0.9%)
Cap. Flow
+$99.9M
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
34.13%
Holding
1,140
New
132
Increased
492
Reduced
188
Closed
50
Avg Time Held
2.9
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$23.9M |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$18.8M |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$14.2M |
| 4 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$13.4M |
| 5 |
Apple
AAPL
|
+$6.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$24.4M |
| 2 |
iShares Gold Trust
IAU
|
+$8.75M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.91M |
| 4 |
Ally Financial
ALLY
|
+$4.53M |
| 5 |
Newmont
NEM
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.9% |
| 2 | Technology | 6.89% |
| 3 | Healthcare | 4.85% |
| 4 | Financials | 4% |
| 5 | Industrials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Ingersoll Rand
IR
$30.2B
| $7K | ﹤0.01% |
169
| – | – |
2020 Q1
10 quarters
|
|
852
MSCI
MSCI
$41.4B
| $7K | ﹤0.01% |
+17
| New | +$7.78K |
2022 Q3
0 quarters
|
|
853
MaxCyte
MXCT
$134M
| $7K | ﹤0.01% |
+1,146
| New | +$6.39K |
2022 Q3
0 quarters
|
|
854
Nutrien
NTR
$34B
| $7K | ﹤0.01% |
80
| – | – |
2021 Q1
6 quarters
|
|
|
OPI
855
DELISTED
Office Properties Income Trust
OPI
| $7K | ﹤0.01% |
484
+5
| +1% | +$94 |
2022 Q2
1 quarter
|
|
856
Schrodinger
SDGR
$1.69B
| $7K | ﹤0.01% |
285
+115
| +68% | +$3.38K |
2022 Q2
1 quarter
|
|
857
First Trust Smith Unconstrained Bond ETF
UCON
$3.15B
| $7K | ﹤0.01% |
300
-41
| -12% | -$1.01K |
2022 Q1
2 quarters
|
|
858
Vulcan Materials
VMC
$33.4B
| $7K | ﹤0.01% |
46
-1
| -2% | -$162 |
2021 Q1
6 quarters
|
|
|
BKI
859
DELISTED
Black Knight, Inc. Common Stock
BKI
| $7K | ﹤0.01% |
101
| – | – |
2021 Q1
6 quarters
|
|
860
Arthur J. Gallagher & Co
AJG
$65.3B
| $6K | ﹤0.01% |
+36
| New | +$6.39K |
2022 Q3
0 quarters
|
|
861
CME Group
CME
$106B
| $6K | ﹤0.01% |
33
| – | – |
2019 Q1
14 quarters
|
|
862
iShares California Muni Bond ETF
CMF
$4.98B
| $6K | ﹤0.01% |
108
| – | – |
2019 Q2
13 quarters
|
|
863
Eaton Vance Enhance Equity Income Fund II
EOS
$1.1B
| $6K | ﹤0.01% |
+405
| New | +$7.18K |
2022 Q3
0 quarters
|
|
864
Evergy
EVRG
$19.2B
| $6K | ﹤0.01% |
103
+31
| +43% | +$2.09K |
2018 Q2
17 quarters
|
|
865
Edwards Lifesciences
EW
$49.9B
| $6K | ﹤0.01% |
69
| – | – |
2021 Q1
6 quarters
|
|
866
First Trust US Equity Opportunities ETF
FPX
$1.38B
| $6K | ﹤0.01% |
70
| – | – |
2019 Q1
14 quarters
|
|
867
Itron
ITRI
$3.64B
| $6K | ﹤0.01% |
150
| – | – |
2021 Q3
4 quarters
|
|
868
iShares Russell 1000 Value ETF
IWD
$83.6B
| $6K | ﹤0.01% |
43
| – | – |
2018 Q1
18 quarters
|
|
869
iShares US Real Estate ETF
IYR
$4.18B
| $6K | ﹤0.01% |
75
| – | – |
2013 Q2
37 quarters
|
|
870
Jack Henry & Associates
JKHY
$10.7B
| $6K | ﹤0.01% |
35
| – | – |
2021 Q1
6 quarters
|
|
871
M&T Bank
MTB
$31.1B
| $6K | ﹤0.01% |
+33
| New | +$5.84K |
2022 Q3
0 quarters
|
|
872
NIO
NIO
$8.59B
| $6K | ﹤0.01% |
+355
| New | +$7.03K |
2022 Q3
0 quarters
|
|
873
Innovator US Equity Power Buffer ETF August
PAUG
$1.04B
| $6K | ﹤0.01% |
+223
| New | +$6.41K |
2022 Q3
0 quarters
|
|
874
PENN Entertainment
PENN
$2B
| $6K | ﹤0.01% |
206
+61
| +42% | +$1.97K |
2020 Q2
9 quarters
|
|
875
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $6K | ﹤0.01% |
78
-140
| -64% | -$10.7K |
2013 Q2
37 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q3 2022 Portfolio in Review
As of Q3 2022, Capital Analysts LLC held 1,140 positions worth $1.45B, up 0.9% from $1.44B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Analysts LLC deployed $99.9M of net new capital in Q3 2022, opening 132 new positions and adding to 492 existing holdings. Its largest new stake was Fidelity MSCI Health Care Index ETF: 64,153 shares worth $3.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 69% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $24.4M trimmed.
- Capital Analysts LLC's largest Q3 2022 buy was Fidelity MSCI Health Care Index ETF: 64,153 shares worth $3.7M.
- Capital Analysts LLC added most to JPMorgan Ultra-Short Income ETF in Q3 2022, an estimated $23.9M increase.
- Capital Analysts LLC's biggest Q3 2022 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $24.4M.
- Capital Analysts LLC fully exited Ally Financial in Q3 2022, selling an estimated $4.53M.
- Capital Analysts LLC's ten largest holdings make up 34% of its $1.45B portfolio in Q3 2022.
- Capital Analysts LLC opened 132 new positions and closed 50 in Q3 2022.
- Capital Analysts LLC's portfolio value rose 0.9% quarter-over-quarter to $1.45B.
Based on Capital Analysts LLC's 13F filing for Q3 2022, filed 14 Nov 2022.